Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Income from Continuing Operations: 2013-2018

Historic Income from Continuing Operations for Armata Pharmaceuticals (ARMP) over the last 6 years, with Dec 2018 value amounting to -$1.1 million.

  • Armata Pharmaceuticals' Income from Continuing Operations rose 53.19% to -$1.1 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$15.9 million, marking a year-over-year decrease of 63.16%. This contributed to the annual value of -$53.2 million for FY2024, which is 22.71% down from last year.
  • Per Armata Pharmaceuticals' latest filing, its Income from Continuing Operations stood at -$1.1 million for Q4 2018, which was up 60.27% from -$2.8 million recorded in Q3 2018.
  • Over the past 5 years, Armata Pharmaceuticals' Income from Continuing Operations peaked at -$779,000 during Q3 2017, and registered a low of -$11.3 million during Q1 2014.
  • Its 3-year average for Income from Continuing Operations is -$3.9 million, with a median of -$3.1 million in 2016.
  • As far as peak fluctuations go, Armata Pharmaceuticals' Income from Continuing Operations tumbled by 691.25% in 2014, and later skyrocketed by 76.61% in 2017.
  • Armata Pharmaceuticals' Income from Continuing Operations (Quarterly) stood at -$2.6 million in 2014, then declined by 10.40% to -$2.9 million in 2015, then crashed by 250.75% to -$10.1 million in 2016, then spiked by 76.61% to -$2.4 million in 2017, then soared by 53.19% to -$1.1 million in 2018.
  • Its Income from Continuing Operations was -$1.1 million in Q4 2018, compared to -$2.8 million in Q3 2018 and -$9.7 million in Q2 2018.